Safety, Efficacy, and Acceptability Study of an Eye Drop Formulation in Subjects With Dry Eye Disease

• Status: Completed
• Trial end date: 2012-02-15
• Target enrollment: 0
• Participant gender: All

Summary

This study will evaluate the safety, efficacy, and acceptability of an eye drop formulation in subjects with dry eye disease.

• Phase: Phase 3
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: Allergan
• Treatments: Carboxymethylcellulose Sodium; Lubricant Eye Drops; Ophthalmic Solutions; Tetrahydrozoline

Criteria

Inclusion Criteria:

• Dry eyes

• Current use of eye drops for dry eye at least twice daily, on average for at least 3 months

Exclusion Criteria:

• Cataract, laser-assisted in situ keratomileusis (LASIK), or photorefractive keratectomy (PRK) surgery in the last 12 months

• Need to wear contact lenses during the study, or has worn contact lenses in the last 6 months

• Active ocular allergy